Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Doximity, Inc. (DOCS)
Then, on April 1, 2024, Jehoshaphat Research published a report alleging, among other things, that "Doximity's underlying sales . . . are declining at a negative 3-6% rate, but that this decline has been masked through accelerated revenue recognition." On this news, Doximity's stock price fell 25.80 per share on April 2, 2024, thereby injuring investors further. The complaint filed in this class action alleges that throughout the Class Period, D ...